RedHill Biopharma (company) logo

RedHill Biopharma (company)

Orally-administered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer

1

Funding Rounds

$48.3m

Money raised

Overview

Orally-administered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer

Industries

RedHill Biopharma (company) is active in the following industries:
  • Biomedical engineering
  • Engineering
  • Biotechnology
  • Pharmaceutical industry